The report analyzes the incidence of ADHD, current options for its treatment, pipeline, market forecasts and deals surrounding ADHD therapeutics.
The global ADHD therapy market is expected to touch USD 9.4 billion by the year 2020. Surprisingly, growth in the market is not driven by drug approvals. Instead the growing prevalence of this disorder increase rates of diagnosis and therefore a suitable treatment population is driving the market.
This report: ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations provides a detailed analysis of the market and focuses on the major players, recent developments and key drivers of the ADHD therapy market.
The ADHD therapy market is currently flooded with generics and is dominated by the use of Extended-Release (ER) stimulant drugs which have overtaken Immediate Release (IR) formulations. Currently in the market, 10% of patients are given a combination of RE and IR treatment for a specific duration. According to reports, there will be three non stimulants which will enter the market alongwith SHP 465.
For further insights,
About Research on Global Markets
Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.
For more details on the content of each report and ordering information please contact:
Email: [email protected]
US: +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
ADHD Therapy, ADHD Research, ADHD Diagnostic